Mukka Proteins JV wins ₹474.89 crore order for leachate treatment
Mukka Proteins' JV secures ₹474.89 crore order for legacy leachate treatment in Bengaluru, marking a strategic diversification into sustainability-driven solutions and environmental conservation.
A substantial order win of ₹474.89 crore represents a significant financial impact and strategic move for the company, indicating a positive outlook.
The announcement highlights a significant new order for the company, indicating potential revenue growth and expansion into a new market segment.
* Mukka Proteins' joint venture has been awarded a ₹474.89 crore contract by Bengaluru Solid Waste Management Limited (BSWML) for scientific treatment of legacy leachate. * Mukka Proteins holds a 76% stake in the JV. * The contract includes treatment and safe disposal of leachate from Mittaganahalli and Kannur landfill sites in Bengaluru. * Construction of the treatment facility is expected to take 6 months, with an overall project duration of 4 years. * The project's CAPEX is estimated at approximately ₹100 crore. * Mr. Kalandan Mohammed Haris, CEO & MD, stated this order marks a transformative milestone for Mukka as they expand capabilities into environmental and sustainability-led solutions.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under new orders. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.